Ishikawa H, Saito K
J Immunol. 1975 Jul;115(1):85-90.
Antigenic competition was studied on reciprocal combinations of non-cross-reacting erythrocyte (RBC) antigens, i.e., sheep erythrocytes (SRBC), horse erythrocytes (HRBC), and chicken erythrocytes (CRBC), as competing antigen or as test antigen. Unlike SRBC and HRBC, CRBC did not induce antigenic competition, and mice previously injected with CRBC showed normal direct and indirect hemolysin plaque-forming cell (PFC) responses to the other RBC subsequently injected. Formaldehyde-treated (F) SRBC that retained the capacity to prime mouse for secondary anti-SRBC antibody response but lost the capacity to elicit primary antibody response also could not induce antigenic competition. CRBC or F-SRBC, i.e., non-competing antigen, included with SRBC interfered with the competition-inducing effect of the latter RBC. When mice that had been injected with SRBC together with either one of the non-competing antigens were subsequently immunized with HRBC their anti-HRBC PFC responses were significantly restored, whereas mice pre-injected with SRBC alone showed markedly suppressed PFC responses to HRBC. Although the non-competing antigen was found not to affect both the direct and indirect PFC responses to the simultaneously injected SRBC, the response of the immune system to the non-competing antigen should alter the concurrent response to SRBC, and probably should prevent the generation of the suppressor thymus-derived (T) lymphocytes, allowing the generation of the helper T lymphocytes for IgM and IgG anti-SRBC antibody formation.
在非交叉反应性红细胞(RBC)抗原的相互组合上研究了抗原竞争,即绵羊红细胞(SRBC)、马红细胞(HRBC)和鸡红细胞(CRBC),作为竞争抗原或测试抗原。与SRBC和HRBC不同,CRBC不会诱导抗原竞争,先前注射过CRBC的小鼠对随后注射的其他RBC表现出正常的直接和间接溶血素空斑形成细胞(PFC)反应。保留引发小鼠二次抗SRBC抗体反应能力但丧失引发初次抗体反应能力的甲醛处理(F)SRBC也不能诱导抗原竞争。与SRBC一起包含的CRBC或F-SRBC,即非竞争抗原,会干扰后者RBC的竞争诱导效应。当用SRBC与其中一种非竞争抗原一起注射的小鼠随后用HRBC免疫时,它们的抗HRBC PFC反应显著恢复,而单独预先注射SRBC的小鼠对HRBC的PFC反应明显受到抑制。尽管发现非竞争抗原不影响对同时注射的SRBC的直接和间接PFC反应,但免疫系统对非竞争抗原的反应应改变对SRBC的同时反应,并且可能应阻止抑制性胸腺来源(T)淋巴细胞的产生,从而允许产生用于IgM和IgG抗SRBC抗体形成的辅助性T淋巴细胞。